Data / Federal awards / NAICS 325414 / Department of Health and Human Services
Department of Health and Human Services contracts under NAICS 325414 Biological Product (except Diagnostic) Manufacturing: $1.9 billion to 222 recipients (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
Department of Health and Human Services obligated $1.9 billion under NAICS 325414, Biological Product (except Diagnostic) Manufacturing, across 936 contract awards to 222 named recipients in fiscal years 2024 to 2027. The largest recipients are ADVANCED TECHNOLOGY INTERNATIONAL ($918.9 million), SANOFI VACCINES US INC. ($700.9 million), EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. ($208.5 million). 4 opportunities under this code are open on SAM.gov now.
The request: Every federal contract awarded by Department of Health and Human Services under NAICS 325414, with the winner, the value and the period of performance. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- Agency
- Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Contract awards
- 936
- Obligated
- $1.9 billion
- Named recipients
- 222
- Small business share of obligations
- 1%
- Full and open competition share
- 93%
- Set aside share
- 0%
- Latest action
- 2026-09-30
Open opportunities in this niche
The same code on SAM.gov, read each morning: 4 opportunities you can still respond to.
Incumbents at this agency
Ranked by dollars obligated in fiscal years 2024 to 2027.
| Recipient | Business size | Awards | Obligated | Share |
|---|---|---|---|---|
| ADVANCED TECHNOLOGY INTERNATIONAL | Other Than Small Business | 10 | $918.9 million | 49.7% |
| SANOFI VACCINES US INC. | Other Than Small Business | 54 | $700.9 million | 37.9% |
| EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | Other Than Small Business | 1 | $208.5 million | 11.3% |
| SEQIRUS INC | Other Than Small Business | 24 | $87.8 million | 4.7% |
| SEQIRUS USA INC | Other Than Small Business | 22 | $42.5 million | 2.3% |
| MILTENYI BIOTEC, INC. | Other Than Small Business | 5 | $5.6 million | 0.3% |
| SOMALOGIC OPERATING CO., INC | Small Business | 9 | $3.4 million | 0.2% |
| JACKSON LABORATORY | Other Than Small Business | 4 | $3.2 million | 0.2% |
| VECTOR BIOMED INC. | Small Business | 3 | $2.1 million | 0.1% |
| 10X GENOMICS, INC. | Other Than Small Business | 44 | $1.9 million | 0.1% |
| LIFE TECHNOLOGIES CORPORATION | Other Than Small Business | 88 | $1.6 million | 0.1% |
| HOLOGIC SALES AND SERVICE, LLC | Other Than Small Business | 2 | $1.4 million | 0.1% |
| ROCHE DIAGNOSTICS CORPORATION | Other Than Small Business | 10 | $915,419 | 0.0% |
| LAMPIRE BIOLOGICAL LABS INC | Small Business | 5 | $861,457 | 0.0% |
| UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | Other Than Small Business | 1 | $749,895 | 0.0% |
| GOVERNMENT SCIENTIFIC SOURCE INC | Small Business | 14 | $682,487 | 0.0% |
| EXPRESSION MANUFACTURING LLC | Small Business | 1 | $648,968 | 0.0% |
| AGILENT TECHNOLOGIES INC | Other Than Small Business | 17 | $550,214 | 0.0% |
| LOYOLA UNIVERSITY OF CHICAGO | Other Than Small Business | 2 | $500,001 | 0.0% |
| FUJIFILM BIOSCIENCES INC. | Other Than Small Business | 5 | $499,238 | 0.0% |
| BIO-RAD LABORATORIES, INC. | Other Than Small Business | 19 | $487,238 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC | Small Business | 8 | $468,383 | 0.0% |
| OXFORD NANOPORE TECHNOLOGIES, INC. | Other Than Small Business | 2 | $451,565 | 0.0% |
| NEW ENGLAND BIOLABS, INC. | Small Business | 21 | $432,026 | 0.0% |
| LIFE TECHNOLOGIES CORPORATION | Other Than Small Business | 18 | $429,774 | 0.0% |
| FISHER SCIENTIFIC COMPANY L.L.C. | Other Than Small Business | 5 | $399,557 | 0.0% |
| BECTON, DICKINSON AND COMPANY | Other Than Small Business | 20 | $395,874 | 0.0% |
| MESO SCALE DIAGNOSTICS LLC | Other Than Small Business | 8 | $387,343 | 0.0% |
| BIOLEGEND, INC. | Other Than Small Business | 18 | $361,622 | 0.0% |
| BATTELLE MEMORIAL INSTITUTE | Other Than Small Business | 11 | $360,526 | 0.0% |
| BRUKER SPATIAL BIOLOGY, INC. | Other Than Small Business | 19 | $352,364 | 0.0% |
| ILLUMINA, INC. | Other Than Small Business | 13 | $318,747 | 0.0% |
| OLINK PROTEOMICS INC | Small Business | 6 | $306,126 | 0.0% |
| PROMEGA CORPORATION | Other Than Small Business | 5 | $298,506 | 0.0% |
| HARDY DIAGNOSTICS | Other Than Small Business | 7 | $272,581 | 0.0% |
| SIGMA-ALDRICH, INC. | Other Than Small Business | 18 | $227,333 | 0.0% |
| DNA TWOPOINTO INC. | Other Than Small Business | 1 | $225,000 | 0.0% |
| FUJIFILM CELLULAR DYNAMICS, INC | Other Than Small Business | 10 | $213,466 | 0.0% |
| TAKARA BIO USA, INC. | Small Business | 10 | $206,531 | 0.0% |
| GEMINI BIOPRODUCTS LLC | Small Business | 9 | $204,331 | 0.0% |
| EMD MILLIPORE CORP | Other Than Small Business | 7 | $199,951 | 0.0% |
| NANOSTRING TECHNOLOGIES, INC. | Small Business | 6 | $196,252 | 0.0% |
| GENSCRIPT USA INC | Small Business | 8 | $195,296 | 0.0% |
| STEMCELL TECHNOLOGIES INC | Other Than Small Business | 12 | $188,238 | 0.0% |
| BIOIVT, LLC | Other Than Small Business | 7 | $186,395 | 0.0% |
| REPLIGEN CORPORATION | Small Business | 1 | $174,560 | 0.0% |
| EUROFINS GENOMICS LLC | Other Than Small Business | 1 | $171,193 | 0.0% |
| ABCAM INC | Other Than Small Business | 9 | $164,147 | 0.0% |
| HORIZON DISCOVERY BIOSCIENCES LIMITED | Other Than Small Business | 3 | $157,820 | 0.0% |
| MABTECH INC | Small Business | 1 | $142,622 | 0.0% |
Offices buying
| Sub agency | Awards | Obligated |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response | 142 | $1.14 billion |
| Centers for Disease Control and Prevention | 78 | $675.7 million |
| National Institutes of Health | 680 | $32.3 million |
| Food and Drug Administration | 32 | $1.5 million |
| Indian Health Service | 3 | $209,983 |
| Office of the Assistant Secretary for Administration | 1 | $0 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $1.58 billion |
| FY2025 | $-86,462,698 |
| FY2026 | $353.4 million |
Products and services bought
| Code | Product or service | Awards | Obligated |
|---|---|---|---|
| AN42 | Health R&d Services; Health Care - Other; Applied Research | 10 | $918.9 million |
| 6505 | Drugs and Biologicals | 493 | $699.7 million |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | 5 | $208.6 million |
| Q999 | Medical- Other | 1 | $53.2 million |
| 6640 | Laboratory Equipment and Supplies | 118 | $9.2 million |
| 6550 | In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | 111 | $7.6 million |
| Q301 | Reference Laboratory Testing | 32 | $5.5 million |
| 9430 | Miscellaneous Crude Animal Products, Inedible | 1 | $567,730 |
Largest contract awards
| Award ID | Recipient | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 75D30123D16111 | SANOFI VACCINES US INC. | Department of Health and Human Services | IDC | 325414 | VACCINES FOR CHILDREN | $526,463,583 | $2,413,810,030 | April 1, 2023 | usaspending.gov | ||
| 75A50124F61002 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM | $303,999,997 | $303,999,997 | January 12, 2024 | March 1, 2030 | Summerville, SC | usaspending.gov |
| 75A50424F64001 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS | $248,500,001 | $248,500,001 | September 27, 2024 | September 29, 2027 | Washington, DC | usaspending.gov |
| 75A50119C00071 | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | Department of Health and Human Services | Definitive Contract | 325414 | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | $208,483,581 | $857,637,641 | August 30, 2019 | September 30, 2026 | Gaithersburg, MD | usaspending.gov |
| 75A50124F61005 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM. | $141,320,194 | $141,320,194 | January 12, 2024 | April 11, 2030 | Summerville, SC | usaspending.gov |
| 75D30124D18412 | SANOFI VACCINES US INC. | Department of Health and Human Services | IDC | 325414 | PEDIATRIC FLU VACCINES 2024-2025 | $88,344,227 | $158,256,000 | January 2, 2024 | usaspending.gov | ||
| 75A50424F64002 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES | $61,000,000 | $61,000,000 | September 30, 2024 | September 29, 2029 | Summerville, SC | usaspending.gov |
| 75A50125C00002 | SANOFI VACCINES US INC. | Department of Health and Human Services | Definitive Contract | 325414 | MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE | $53,212,199 | $53,212,199 | February 1, 2025 | January 31, 2027 | Swiftwater, PA | usaspending.gov |
| 75A50124F61004 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | OTHER TRANSACTION: SUSTAINMENT OF PPE CAPACITIES - NITRILE BUTADIENE RUBBER | $50,679,329 | $50,679,329 | January 12, 2024 | April 11, 2029 | Summerville, SC | usaspending.gov |
| 75A50120D00002 | SANOFI VACCINES US INC. | Department of Health and Human Services | IDC | 325414 | DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES | $44,000,000 | $6,338,039,491 | December 5, 2019 | usaspending.gov | ||
| 75A50126F61015 | SEQIRUS INC | Department of Health and Human Services | Delivery Order | 325414 | FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICAL TRIAL IMPLEMENTATION | $42,769,479 | $42,769,479 | September 30, 2026 | March 29, 2030 | Holly Springs, NC | usaspending.gov |
| 75D30124D18414 | SEQIRUS USA INC | Department of Health and Human Services | IDC | 325414 | PEDIATRIC FLU VACCINES 2024-2025 | $40,176,661 | $318,010,000 | January 2, 2024 | usaspending.gov | ||
| 75A50124F61003 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | DEVELOPMENT OF E-BEAM AND/OR X-RAY STERILIZATION CAPACITY FOR DOMESTIC STERILIZATION CAPACITY UNDER THE BIOMAP-CONSORTIUM | $38,000,006 | $38,000,006 | January 12, 2024 | June 11, 2037 | Summerville, SC | usaspending.gov |
| 75A50124F61001 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL IN | $32,000,000 | $32,000,000 | December 12, 2023 | December 31, 2027 | Summerville, SC | usaspending.gov |
| 75A50124F61008 | SEQIRUS INC | Department of Health and Human Services | Delivery Order | 325414 | THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND | $23,270,752 | $23,270,752 | February 22, 2024 | May 21, 2027 | Holly Springs, NC | usaspending.gov |
| 75A50124F61007 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | OTA AWARD FOR BIOMAP TASK ORDER #7 FOR CBRN AVAT_MRNA | $19,620,884 | $19,620,884 | June 20, 2024 | September 30, 2029 | Summerville, SC | usaspending.gov |
| 75A50124F61010 | SEQIRUS INC | Department of Health and Human Services | Delivery Order | 325414 | THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND | $18,790,750 | $18,790,750 | May 3, 2024 | May 2, 2026 | Holly Springs, NC | usaspending.gov |
| 75A50124F61006 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | Delivery Order | 325414 | OTHER TRANSACTION: INDUSTRIAL BASE EXPANSION OF INJECTION MOLDED PIPETTE TIPS AND CENTRIFUGE TUBES. | $16,379,368 | $16,379,368 | March 1, 2024 | September 29, 2033 | Summerville, SC | usaspending.gov |
| 75A50123D00003 | ADVANCED TECHNOLOGY INTERNATIONAL | Department of Health and Human Services | IDC | 325414 | OTHER TRANSACTION: BIOPHARMACEUTICAL MANUFACTURING PREPAREDNESS CONSORTIUM (BIOMAP-CONSORTIUM) | $7,416,630 | $20,000,000,000 | September 30, 2023 | usaspending.gov | ||
| 75D30124D19013 | NOVAVAX INC | Department of Health and Human Services | IDC | 325414 | COVID-19 PEDIATRIC VACCINES | $5,806,670 | $7,756,250 | June 1, 2024 | usaspending.gov | ||
| 75D30124D19012 | NOVAVAX INC | Department of Health and Human Services | IDC | 325414 | COVID-19 ADULT VACCINES | $4,260,390 | $13,961,250 | June 1, 2024 | usaspending.gov | ||
| 75N90023D00015 | MILTENYI BIOTEC, INC. | Department of Health and Human Services | IDC | 325414 | MILTENYI CLINIMACS CELL ISOLATION REAGENTS AND CONSUMABLES | $3,905,000 | $5,773,875 | June 26, 2023 | usaspending.gov | ||
| 75D30124D18411 | SANOFI VACCINES US INC. | Department of Health and Human Services | IDC | 325414 | ADULT FLU VACCINES 2024-2025 | $2,630,659 | $64,529,959 | January 2, 2024 | usaspending.gov | ||
| 75D30124D18413 | SEQIRUS USA INC | Department of Health and Human Services | IDC | 325414 | ADULT FLU VACCINES 2024-2025 | $2,512,156 | $215,741,000 | January 2, 2024 | usaspending.gov | ||
| 75A50126F61014 | SEQIRUS INC | Department of Health and Human Services | Delivery Order | 325414 | MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS) | $2,148,912 | $2,148,912 | September 30, 2026 | September 29, 2028 | Holly Springs, NC | usaspending.gov |
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.